Net Income (Loss) Per Share Attributable to Common Stockholders (Tables)

9 Months Ended

Oct. 31, 2025

Earnings Per Share [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the computation of the basic and diluted net income (loss) per share attributable to common stockholders:

	Three months ended October 31,				Nine months ended October 31,
(in thousands, except share and per share data)	2025		2024		2025		2024
Basic net income (loss) per share:
Numerator:
Net income (loss) attributable to common stockholders	$	6,136	$	(12,799)	$	33,657	$	(20,673)
Denominator:
Weighted-average common shares outstanding, basic	123,151,525		128,036,993		123,866,513		126,668,394
Net income (loss) per share:
Net income (loss) per share attributable to common stockholders, basic	$	0.05	$	(0.10)	$	0.27	$	(0.16)
Diluted net income (loss) per share:
Numerator:
Net income (loss)	$	6,136	$	(12,799)	$	33,657	$	(20,673)
Fair value adjustment related to contingent consideration	(4,300)		—		(25,900)		—
Net income (loss), diluted	$	1,836	$	(12,799)	$	7,757	$	(20,673)
Denominator:
Number of shares used in basic calculation	123,151,525		128,036,993		123,866,513		126,668,394
Dilutive effect of employee share-based awards	4,169,723		—		4,596,856		—
Dilutive effect of incentive pool	156,031		—		888,593		—
Dilutive effect of earnout arrangement	1,411,532		—		949,215		—
Weighted-average common shares outstanding, diluted	128,888,811		128,036,993		130,301,177		126,668,394
Net income (loss) per share attributable to common stockholders, diluted	$	0.01	$	(0.10)	$	0.06	$	(0.16)

Schedule of Antidilutive Securities

Anti-dilutive common equivalent shares were as follows:

	Three months ended October 31,		Nine months ended October 31,
	2025	2024	2025	2024
Options to purchase common stock	126,750	1,612,009	380,881	1,612,009
Restricted stock and restricted stock units	260,884	10,918,443	1,965,779	10,918,443
Shares estimated to be purchased under ESPP	—	359,798	—	359,798
Performance-based restricted stock units	2,000,000	3,530,000	2,575,000	3,530,000
Total anti-dilutive common equivalent shares	2,387,634	16,420,250	4,921,660	16,420,250